RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy.

Front Oncol · 2025 · PMC12586144 · PMID 41199843

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The AUC of the combination of RAD51 expression and the KELIM score showed an increasing trend compared with the KELIM score and RAD51 expression respectively, yet there was no statistical difference among the three.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.